All News
Youth age 12 – 18 who use marijuana are 4 – 7 times more likely than adults to develop a cannabis use disorder.
Winters KC and Lee CY. Likelihood of developing an alcohol and cannabis use disorder during youth: Association with recent use and age. Drug Alcohol Depend. 2008;92(1-3):239-247.https://www.sciencedirect.com/science/article/abs/pii/S0376871607002979
The brain cycle of addiction applied to people who have a cannabis use disorder similar to other drugs of abuse.
https://link.springer.com/article/10.1007%2Fs11481-018-9782-9
When parents use marijuana, they increase the risk of their marijuana, tobacco and alcohol use and opioid misuse in their children.
https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2755867
Youth marijuana addiction is double rate of alcohol addiction
https://jamanetwork.com/journals/jamapediatrics/article-abstract/2777817?resultClick=1
Listen to podcast High Truths on Drugs and Addiction on your favorite platform. Hightruth.com
Most Recent News
IASIC Speaker Series Presents: Impacts of Maternal Cannabis Use on Long-Term Psychiatric Risk
The International Academy on the Science and Impact of Cannabis (IASIC) is excited to present the IASIC Speaker Series. Presented free of charge, this ongoing educational seminar series will focus on the science, data and peer-reviewed research surrounding marijuana and will be led by international medical experts. This non-partisan and non-political series is continually developed,
Libby Stuyt Interview on Randy Tobler show
Exciting News! Libby Stuyt’s Interview on Randy Tobler Show! Hey everyone, we wanted to share some thrilling news! The brilliant Dr. Libby Stuyt recently had an enlightening interview on Randy Tobler Show. Dr. Stuyt is known for her groundbreaking work in the field of addiction medicine and mental health. Her insights are nothing short of
Balancing risks and benefits of cannabis use: umbrella review of meta-analyses of randomised controlled trials and observational studies
Introduction Cannabis contains over 100 cannabinoids, of which Δ9-tetrahydrocannabinol and cannabidiol are the most clinically relevant. Tetrahydrocannabinol is a partial agonist at CB1 and binds CB2 receptors. CB1 is widely expressed by central and peripheral neurones but also by immune cells and other type of cells in the brain and in the periphery, and when
IASIC Speaker Series Presents: Case Report on Cannabis-Induced Acute Encephalopathy in Elderly After Taking CBD
The International Academy on the Science and Impact of Cannabis (IASIC) is excited to present the IASIC Speaker Series. Presented free of charge, this ongoing educational seminar series will focus on the science, data and peer-reviewed research surrounding marijuana and will be led by international medical experts. This non-partisan and non-political series is continually developed,